InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: Rymankoly post# 1914

Sunday, 06/30/2013 8:47:09 PM

Sunday, June 30, 2013 8:47:09 PM

Post# of 4817
I can't remember anyone posting the information about the approval guidance from the Office of Combination Products (OCP) division of the FDA. I doubt Adam Feuerstein was even aware of the details & I don't recall ATRS's management ever mentioning this. His article gave a wealth of information & I don't think investors appreciate his work.


I also can't wait to see Ali's rebuttal to any bashing SM can come up with about QST,